Cited by 0

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

The Effectiveness of a Multidisciplinary Integrative Survivorship Program for Cancer-Related Cognitive Impairment: A Prospective Cohort Study

Vanlaer, Nathalie, Testaferrata, Camille, Decabooter, Lynn, Dirven, Iris, Bertels, Cleo, Stas, Lara, Van Eycken, Sebastien, Hein, Matthieu, Neyns, Bart, Rogiers, Anne·2026·Cancers

Abstract

Background: Cancer-related cognitive impairment (CRCI) affects quality of life, daily functioning and return-to-work. However, CRCI remains under-addressed in cancer care. Since cognitive complaints often co-occur with fatigue and psychological distress, a multimodal approach is warranted. We developed Integrative Neuro-Cognitive Remediation Therapy (INCRT), a multidisciplinary survivorship program combining personalized cognitive function and strategy training with group-based psychoeducation, cognitive–behavioral therapy and Acceptance and Commitment Therapy, and onco-yoga. Methods: Cancer survivors suffering from CRCI were eligible. Assessments included neuropsychological testing, patient-reported outcomes, and daily functioning at baseline (T0), post-intervention (T1), and 6-month follow-up (T2). Primary outcomes were objective and subjective neurocognitive functioning (NCF); secondary outcomes were psychological distress, fatigue, metacognition, and daily functioning. Changes were analyzed using linear mixed models. Results: Between November 2022 and January 2025, 44 of 56 eligible survivors enrolled; 38 completed the program (71.1% female; median age 53.5). Objective and subjective NCF improved significantly at T1 and T2 (ps < 0.001). Psychological distress, fatigue, and unhelpful metacognitions decreased over time (ps < 0.05). Participants reported greater emotional and cognitive insight and improved daily functioning. Conclusions: INCRT improves cognitive functioning, reduces psychological distress and fatigue, and enhances daily functioning, with benefits maintained at follow-up. The integrative design supports sustained effects by promoting internalization and daily application of learned strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers18050785

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 52

  1. Demuru, 2024, Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): A population-based study, Lancet Oncol., 25, 293, 10.1016/S1470-2045(23)00646-0 · DOI
  2. Tonorezos, 2024, Prevalence of cancer survivors in the United States, JNCI J. Natl. Cancer Inst., 116, 1784, 10.1093/jnci/djae135 · DOI
  3. Masiero, 2022, ESMO Expert Consensus Statements on Cancer Survivorship: Promoting high-quality survivorship care and research in Europe, Ann. Oncol., 33, 1119, 10.1016/j.annonc.2022.07.1941 · DOI · Paper page
  4. Rogiers, 2019, Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: A longitudinal pilot study, Support. Care Cancer, 28, 3267
  5. Rogiers, 2020, Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab, J. Immunol. Res., 2020, 2192480, 10.1155/2020/2192480 · DOI
  6. Vanlaer, N., Dirven, I., Neyns, B., and Rogiers, A. (2024). Emotional Distress, Cognitive Complaints, and Care Needs among Advanced Cancer Survivors Treated with Immune Checkpoint Blockade: A Mixed-Method Study. Cancers, 16. · DOI
  7. Lange, 2019, Cognitive complaints in cancer survivors and expectations for support: Results from a web–based survey, Cancer Med., 8, 2654, 10.1002/cam4.2069 · DOI
  8. Klaver, 2019, Cancer-related cognitive problems at work: Experiences of survivors and professionals, J. Cancer Surviv., 14, 168, 10.1007/s11764-019-00830-5 · DOI
  9. Sleurs, 2022, Cancer-related cognitive impairment in non-CNS cancer patients: Targeted review and future action plans in Europe, Crit. Rev. Oncol., 180, 103859, 10.1016/j.critrevonc.2022.103859 · DOI
  10. Lange, 2019, Cancer-related cognitive impairment: An update on state of the art, detection, and management strategies in cancer survivors, Ann. Oncol., 30, 1925, 10.1093/annonc/mdz410 · DOI
  11. Vardy, 2015, Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study, J. Clin. Oncol., 33, 4085, 10.1200/JCO.2015.63.0905 · DOI
  12. Whittaker, 2022, Prevalence of cognitive impairment following chemotherapy treatment for breast cancer: A systematic review and meta-analysis, Sci. Rep., 12, 2135, 10.1038/s41598-022-05682-1 · DOI
  13. Ho, 2024, Prevalence and assessment tools of cancer-related cognitive impairment in lung cancer survivors: A systematic review and proportional meta-analysis, Support. Care Cancer, 32, 209
  14. Mayo, 2024, Cognitive Symptoms Across Diverse Cancers, JAMA Netw. Open, 7, e2430833, 10.1001/jamanetworkopen.2024.30833 · DOI
  15. Sanft, 2023, NCCN Guidelines® Insights: Survivorship, Version 1.2023, J. Natl. Compr. Cancer Netw., 21, 792, 10.6004/jnccn.2023.0041 · DOI
  16. Simard, 2013, Fear of cancer recurrence in adult cancer survivors: A systematic review of quantitative studies, J. Cancer Surviv., 7, 300, 10.1007/s11764-013-0272-z · DOI · Paper page
  17. Liu, 2016, Cancer in Europe: Death sentence or life sentence?, Eur. J. Cancer, 65, 150, 10.1016/j.ejca.2016.07.007 · DOI
  18. Schagen, 2022, Cognitive adverse effects of chemotherapy and immunotherapy: Are interventions within reach?, Nat. Rev. Neurol., 18, 173, 10.1038/s41582-021-00617-2 · DOI
  19. Hutchinson, 2012, Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review, Cancer Treat. Rev., 38, 926, 10.1016/j.ctrv.2012.05.002 · DOI
  20. Gutenkunst, 2020, Correlates of cognitive impairment in adult cancer survivors who have received chemotherapy and report cognitive problems, Support. Care Cancer, 29, 1377
  21. Haywood, 2025, The effect of non-pharmacological interventions on cognitive function in cancer: An overview of systematic reviews, Support. Care Cancer, 33, 151
  22. Maeir, 2023, Cognitive Retraining and Functional Treatment (CRAFT) for adults with cancer related cognitive impairment: A preliminary efficacy study, Support. Care Cancer, 31, 152
  23. Nguyen, 2021, A Game a Day Keeps Cognitive Decline Away? A Systematic Review and Meta-Analysis of Commercially-Available Brain Training Programs in Healthy and Cognitively Impaired Older Adults, Neuropsychol. Rev., 32, 601, 10.1007/s11065-021-09515-2 · DOI
  24. Wykes, 2011, A Meta-Analysis of Cognitive Remediation for Schizophrenia: Methodology and Effect Sizes, Am. J. Psychiatry, 168, 472, 10.1176/appi.ajp.2010.10060855 · DOI · Paper page
  25. McGurk, 2007, A Meta-Analysis of Cognitive Remediation in Schizophrenia, Am. J. Psychiatry, 164, 1791, 10.1176/appi.ajp.2007.07060906 · DOI · Paper page
  26. Duncan, 2017, Review of systematic reviews of non-pharmacological interventions to improve quality of life in cancer survivors, BMJ Open, 7, e015860, 10.1136/bmjopen-2017-015860 · DOI
  27. Mesas, 2022, Immediate effect of high-intensity exercise on brain-derived neurotrophic factor in healthy young adults: A systematic review and meta-analysis, J. Sport Health Sci., 11, 367, 10.1016/j.jshs.2021.08.004 · DOI
  28. Kennedy, 2016, How Does Exercise Reduce the Rate of Age-Associated Cognitive Decline? A Review of Potential Mechanisms, J. Alzheimer’s Dis., 55, 1, 10.3233/JAD-160665 · DOI
  29. Dieng, 2016, Psychoeducational Intervention to Reduce Fear of Cancer Recurrence in People at High Risk of Developing Another Primary Melanoma: Results of a Randomized Controlled Trial, J. Clin. Oncol., 34, 4405, 10.1200/JCO.2016.68.2278 · DOI · Paper page
  30. Bernstein, 2018, A brief psychoeducational intervention improves memory contentment in breast cancer survivors with cognitive concerns: Results of a single-arm prospective study, Support. Care Cancer, 26, 2851
  31. Osborn, 2006, Psychosocial Interventions for Depression, Anxiety, and Quality of Life in Cancer Survivors: Meta-Analyses, Int. J. Psychiatry Med., 36, 13, 10.2190/EUFN-RV1K-Y3TR-FK0L · DOI · Paper page
  32. Mathew, 2020, Acceptance and commitment therapy in adult cancer survivors: A systematic review and conceptual model, J. Cancer Surviv., 15, 427, 10.1007/s11764-020-00938-z · DOI · Paper page
  33. Huang, 2015, A meta-analysis of the benefits of mindfulness-based stress reduction (MBSR) on psychological function among breast cancer (BC) survivors, Breast Cancer, 23, 568, 10.1007/s12282-015-0604-0 · DOI · Paper page
  34. Ahmadoun, 2020, Effects of a mindfulness-based intervention on cancer-related cognitive impairment: Results of a randomized controlled functional magnetic resonance imaging pilot study, Cancer, 126, 4246, 10.1002/cncr.33074 · DOI
  35. Bower, 2012, Yoga for persistent fatigue in breast cancer survivors: A randomized controlled trial, Cancer, 118, 3766, 10.1002/cncr.26702 · DOI · Paper page
  36. Wefel, 2011, International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer, Lancet Oncol., 12, 703, 10.1016/S1470-2045(10)70294-1 · DOI
  37. Broadbent, 1982, The Cognitive Failures Questionnaire (CFQ) and its correlates, Br. J. Clin. Psychol., 21, 1, 10.1111/j.2044-8260.1982.tb01421.x · DOI
  38. Ponds, 2006, De Cognitive Failure Questionnaire als maat voor subjectief cognitief functioneren, Tijdschr. Neuropsychol., 2, 37
  39. Spinhoven, 1997, A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects, Psychol. Med., 27, 363, 10.1017/S0033291796004382 · DOI · Paper page
  40. Castelli, 2010, Fast screening of depression in cancer patients: The effectiveness of the HADS, Eur. J. Cancer Care, 20, 528
  41. Krupp, 1989, Steinberg ADThe fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus, Arch. Neurol., 46, 1121, 10.1001/archneur.1989.00520460115022 · DOI · Paper page
  42. Wells, 2004, A short form of the metacognitions questionnaire: Properties of the MCQ-30, Behav. Res. Ther., 42, 385, 10.1016/S0005-7967(03)00147-5 · DOI · Paper page
  43. Cook, S.A., Salmon, P., Dunn, G., and Fisher, P. (2014). Measuring Metacognition in Cancer: Validation of the Metacognitions Questionnaire 30 (MCQ-30). PLoS ONE, 9. · DOI
  44. Spielberger, C.D., Gorsuch, R., Lushene, R.E., Vagg, P.R., and Jacobs, G.A. (1983). Manual for the State-Trait Anxiety Inventory (Form Y1—Y2), Consulting Psychologists Press.
  45. Simard, 2015, Screening and comorbidity of clinical levels of fear of cancer recurrence, J. Cancer Surviv., 9, 481, 10.1007/s11764-015-0424-4 · DOI · Paper page
  46. Smith, 2020, Spotlight on the Fear of Cancer Recurrence Inventory (FCRI), Psychol. Res. Behav. Manag., 13, 1257, 10.2147/PRBM.S231577 · DOI · Paper page
  47. Wang, 2013, Psychometric properties of the Beck Depression Inventory-II: A comprehensive review, Rev. Bras. Psiquiatr., 35, 416, 10.1590/1516-4446-2012-1048 · DOI · Paper page
  48. Frost, 1990, The dimensions of perfectionism, Cogn. Ther. Res., 14, 449, 10.1007/BF01172967 · DOI · Paper page
  49. Jacobson, 1991, Clinical significance: A statistical approach to defining meaningful change in psychotherapy research, J. Consult. Clin. Psychol., 59, 12, 10.1037/0022-006X.59.1.12 · DOI · Paper page
  50. Wolfe, D.M., Hamel, C., Berard, J., Veroniki, A.A., Skidmore, B., Kanji, S., Rabheru, K., McGee, S.F., Forbes, L., and Machado, I.D.L. (2025). Comparative Effectiveness of Interventions to Treat Cancer Treatment-Related Cognitive Impairment in Adult Cancer Survivors Following Systemic Therapy: A Systematic Review with Network Meta-Analyses. Cancers, 17. · DOI
  51. Cherrier, 2021, Cognitive skill training improves memory, function, and use of cognitive strategies in cancer survivors, Support. Care Cancer, 30, 711
  52. Yang, 2025, Cognitive training for breast cancer patients with cancer-related cognitive impairment: A scoping review, Support. Care Cancer, 33, 1038

Metadata

Authors
Vanlaer, N., Testaferrata, C., Decabooter, L., Dirven, I., Bertels, C., Stas, L., Van Eycken, S., Hein, M., Neyns, B., & Rogiers, A.
Venue
Cancers
Publisher
MDPI AG
Published
2026-02-28
Volume
18
Issue
5
Pages
785
ISSN
2072-6694
Cited by
0
References
2
Language
en
Funders
Research Foundation Flanders (FWO), Belgium (11N9425N)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review